Adjusting Exposure Limits for Long and Short Exposure Periods Using A Physiological Pharmacokinetic Model

article

Adjusting Exposure Limits for Long and Short Exposure Periods Using A Physiological Pharmacokinetic Model is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/15298668791384850
P698PubMed publication ID3591649

P2093author name stringMELVIN E. ANDERSEN
DENNIS J. PAUSTENBACH
HARVEY J. CLEWELL III
MICHAEL G. MacNAUGHTON
P433issue4
P921main subjectpharmacokineticsQ323936
P304page(s)335-343
P577publication date1987-04-01
P1433published inAIHA JournalQ23928734
P1476titleAdjusting Exposure Limits for Long and Short Exposure Periods Using A Physiological Pharmacokinetic Model
P478volume48

Reverse relations

cites work (P2860)
Q24815444A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment
Q46098375A linear systems approach to analyzing the pharmacokinetics of carbon tetrachloride in the rat following repeated exposures of 8 and 11.5 h/day
Q23912442Advances in inhalation dosimetry models and methods for occupational risk assessment and exposure limit derivation
Q44652067Application of a Physiologically Based Pharmacokinetic Model for Reference Dose and Reference Concentration Estimation for Acetone
Q37799612Benzene and human health: A historical review and appraisal of associations with various diseases
Q37916566Challenges in the application of quantitative approaches in risk assessment: a case study with di-(2-ethylhexyl)phthalate
Q37660328Development and utilization of physiologically based pharmacokinetic models for toxicological applications
Q46603013Duration adjustment of acute exposure guideline level values for trichloroethylene using a physiologically-based pharmacokinetic model
Q35188620Inhalation Anesthesia Using Physiologically Based Pharmacokinetic Models
Q46601305Moving from external exposure concentration to internal dose: duration extrapolation based on physiologically based pharmacokinetic derived estimates of internal dose
Q30503509Neurotoxic and pharmacokinetic responses to trichloroethylene as a function of exposure scenario
Q43215636Physiologically based pharmacokinetic modeling using microsoft excel and visual basic for applications
Q35802386The Acute Exposure Guideline Level (AEGL) program: applications of physiologically based pharmacokinetic modeling
Q37781049The role of exposure reconstruction in occupational human health risk assessment: current methods and a recommended framework
Q41678849Updating OSHA's permissible exposure limits: putting politics aside

Search more.